Key facts
- This page summarizes Brett Soloway's Form 4 filing for Cushman & Wakefield plc (CWK).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 09 Mar 2022, 17:46.
Brett Soloway - 07 Mar 2022 Form 4 Insider Report for Cushman & Wakefield plc (CWK)
- Reporting relationship
- Executive VP General Counsel and Corporate Secretary
- Issuer ticker
- CWK
- Reported as of
- 07 Mar 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 09 Mar 2022, 17:46:55 UTC
- Prior SEC filing
- 01 Mar 2022
- Next SEC filing
- 28 Feb 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Brett Soloway
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Brett Soloway filed Form 4 for Cushman & Wakefield plc (CWK) on 09 Mar 2022.
Change
- Previous filing in this sequence was filed on 01 Mar 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CWK
transaction
Ordinary Shares
Options Exercise
- Transaction value
- $0
- Shares
- +6,723
- Change %
- +4.3%
- Price
- $0.000000
- Shares after
- 163,639
- Date
- 07 Mar 2022
- Ownership
- Direct
- Footnotes
- F1
CWK
transaction
Ordinary Shares
Award
- Transaction value
- $0
- Shares
- +15,955
- Change %
- +9.8%
- Price
- $0.000000
- Shares after
- 179,594
- Date
- 07 Mar 2022
- Ownership
- Direct
- Footnotes
- F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CWK
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -6,723
- Change %
- -50%
- Price
- $0.000000
- Shares after
- 6,722
- Date
- 07 Mar 2022
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 6,723
- Exercise price
- Footnotes
- F1, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Conversion of previously awarded restricted stock units ("RSUs") into an equal number of ordinary shares, without the payment of any consideration, pursuant to the Amended & Restated Cushman & Wakefield plc 2018 Omnibus Management Share and Cash Incentive Plan (the "A&R Omnibus Plan").
Footnote F2
Represents vesting of ordinary shares earned in respect of performance-based restricted stock units ("PBRSUs") based on the achievement by the Issuer of certain performance targets for the 2019-2022 performance period pursuant to the A&R Omnibus Plan. The reporting person has elected to defer settlement of award until the earlier of January 2024 or termination under the Cushman & Wakefield plc Deferred Compensation Plan (the "Deferred Compensation Plan").
Footnote F3
RSUs were granted on March 7, 2019 and vest on the anniversary of the grant date in four (4) substantially equal installments on each of the first four (4) anniversaries of the grant date, subject, with certain limited exceptions, to the reporting person's continuing employment through each such vesting date. The reporting person has elected to defer settlement of award until the earlier of January 2024 or termination under the Deferred Compensation Plan.
SEC remarks
Executive VP General Counsel and Corporate Secretary